207 related articles for article (PubMed ID: 4612973)
1. [Immunologic paralysis during tumor growth].
Shats VIa
Vopr Onkol; 1974; 20(11):85-95. PubMed ID: 4612973
[No Abstract] [Full Text] [Related]
2. [Cancer and the lymphatic system].
Grekh IF
Vopr Onkol; 1971 Sep; 17(10):101-10. PubMed ID: 4947716
[No Abstract] [Full Text] [Related]
3. Normal and neoplastic lymphocyte maturation.
Weissman IL; McGrath MS; Pillemer E; Hollander N; Rouse RV; Jerabek L; Stevens SK; Scollay RG; Butcher EC
J Supramol Struct Cell Biochem; 1981; 15(3):303-14. PubMed ID: 6790720
[No Abstract] [Full Text] [Related]
4. [Current and prospective problems in tumor immunology].
Pitzurra M
Boll Ist Sieroter Milan; 1971; 50(3):209-20. PubMed ID: 4947785
[No Abstract] [Full Text] [Related]
5. Aspects of immunology in radiotherapy.
James KW
Mod Trends Radiother; 1972; 2():77-97. PubMed ID: 4563804
[No Abstract] [Full Text] [Related]
6. [Principal immunologic factors in carcinogenesis].
Melki G
Cah Med; 1973 Oct; 14(10):821-37. PubMed ID: 4806157
[No Abstract] [Full Text] [Related]
7. Immunological activation of oncogenic viruses: interrelationship of immunostimulation and immunosuppression.
Hirsch MS
Johns Hopkins Med J Suppl; 1974; 3():177-85. PubMed ID: 4153909
[No Abstract] [Full Text] [Related]
8. Alloantisera reacting with tumor cells of inappropriate haplotype. I. Characterization of target antigens.
Prat M; Rogers MJ; Appella E
J Natl Cancer Inst; 1978 Aug; 61(2):527-34. PubMed ID: 79659
[No Abstract] [Full Text] [Related]
9. [Thymus and carcinogenesis. The genetic aspect of the problem].
Gruntenko EV
Usp Sovrem Biol; 1973; 75(2):278-94. PubMed ID: 4574951
[No Abstract] [Full Text] [Related]
10. Depression of antilymphoma allograft reactivity by tumor-associated factors.
Bonmassar E; Bonmassar A; Goldin A; Cudkowicz G
Cancer Res; 1973 May; 33(5):1054-61. PubMed ID: 4703118
[No Abstract] [Full Text] [Related]
11. Cellular immune reactions in human acute leukemia.
Herberman RB
Hamatol Bluttransfus; 1974; 14():107-18. PubMed ID: 4615044
[No Abstract] [Full Text] [Related]
12. [Blood lymphocytes in cancer].
Shats VIa
Tsitologiia; 1972 Jan; 14(1):3-12. PubMed ID: 4551781
[No Abstract] [Full Text] [Related]
13. Immunological reactions to tumor-associated antigens in Burkitts lymphoma and other lymphomas.
Herberman RB; McCoy JL; Levine PH
Cancer Res; 1974 May; 34(5):1222-7. PubMed ID: 4366992
[No Abstract] [Full Text] [Related]
14. Combined neoplastic effects of vaccinia virus and 3-methylcholanthrene. I. Studies with mice of different inbred strains.
Duran-Reynals ML
J Natl Cancer Inst; 1972 Jan; 48(1):95-104. PubMed ID: 4652378
[No Abstract] [Full Text] [Related]
15. Drug-mediated changes of tumour cell immunogenicity and antigenicity.
Puccetti P; Romani L; Taramelli D; Bonmassar E; Fioretti MC
Int J Tissue React; 1982; 4(3):189-99. PubMed ID: 6183194
[No Abstract] [Full Text] [Related]
16. Mechanisms of tumor-induced immunological deficiencies and their possible significance in relation to the use of immunopotentiators in tumor-bearing hosts.
Kerbel RS
Biomedicine; 1974 Jul; 21(7):253-61. PubMed ID: 4547979
[No Abstract] [Full Text] [Related]
17. Immune reactivity to tumor antigens in leukemia and lymphoma.
Leventhal BG; Mirro J; Yarbro GS
Semin Hematol; 1978 Apr; 15(2):157-79. PubMed ID: 148730
[No Abstract] [Full Text] [Related]
18. [Importance of specific and nonspecific immunity in anti-tumor defense].
Biozzi G; Stiffel C; Mouton D; Bouthillier Y; Decreusefond C
Ann Inst Pasteur (Paris); 1972 Apr; 122(4):685-94. PubMed ID: 5050875
[No Abstract] [Full Text] [Related]
19. Delayed cutaneous hypersensitivity to oxazolone in mice with tumors.
Hemsworth GR; Wolff JS; Kraska AR; Jensen KE
Cancer Res; 1978 Apr; 38(4):907-10. PubMed ID: 639044
[TBL] [Abstract][Full Text] [Related]
20. [Immunologic response to transplantable specific antigens in experimental tumors].
Porwit-Bóbr Z
Postepy Hig Med Dosw; 1971; 25(1):25-36. PubMed ID: 4932042
[No Abstract] [Full Text] [Related]
[Next] [New Search]
